Form 4: Co-Diagnostics CFO Brian Brown Reports Routine Stock Transactions Following RSU Vesting

Co-Diagnostics, Inc.'s Chief Financial Officer, Brian Lee Brown, reported the vesting of 134,166 restricted stock units and the subsequent sale of 48,161 shares to cover tax obligations.

Summary

• Brian Lee Brown, Chief Financial Officer of Co-Diagnostics, Inc. (CODX), reported stock transactions on May 23, 2025, as detailed in a Form 4 filing.
• He acquired 134,166 shares of common stock through the vesting of restricted stock units (RSUs) at a price of $0.00 per share.
• Following this acquisition, his direct beneficial ownership of common stock increased to 554,072 shares.
• Concurrently, Mr. Brown disposed of 48,161 shares of common stock at a price of $0.24 per share.
• This disposition was a 'sell to cover' transaction, mandated by the company's equity incentive plans to satisfy tax withholding obligations related to the RSU vesting, and was explicitly stated as not a discretionary trade by the Reporting Person.
• After both the acquisition and disposition, his direct beneficial ownership of common stock stands at 505,911 shares.
• His remaining beneficial ownership of derivative securities, specifically Restricted Stock Units, is 246,667 units.

Sentiment

Score: 7

Explanation: The filing indicates routine executive compensation vesting and a non-discretionary sale for tax purposes, which is a neutral to slightly positive event as it reflects ongoing executive alignment and retention. No negative discretionary actions were taken.

Positives

• The vesting of 134,166 restricted stock units indicates continued compensation and retention of a key executive, Brian Lee Brown.
• The RSU awards are part of the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, which aims to align executive interests with shareholder value over time.

Negatives

• The sale of 48,161 shares, while non-discretionary and for tax purposes, represents a reduction in the executive's direct shareholding.

Future Outlook

N/A. This Form 4 filing reports past transactions and does not provide forward-looking statements or guidance.

Management Comments

• "This sale is mandated by the Issuer's election, under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person."

Industry Context

This filing is a routine insider transaction report and does not provide information relevant to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The vesting and subsequent tax-related sale are routine and expected, reflecting the company's executive compensation structure. The executive retains a significant stake, aligning interests.
• Employees: The RSU plan is a form of employee incentive, potentially positive for morale and retention.

Key Dates

Recommendation

Keywords

Co-Diagnostics, CODX, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Sell to Cover, Executive Compensation, Brian Lee Brown, Chief Financial Officer, Stock Transaction, Beneficial Ownership